MedTrace Logo

Identification and Characterization of Molecular Markers in Musculoskeletal Tumors

NCT02199938 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2018-10-02

No results posted yet for this study

Summary

The aim of the study is to improve the understanding of molecular mechanisms in the development and progression of musculoskeletal tumors. These tumors do have in general unfavorable prognosis and conventional treatments (e.g. surgery, radiotherapy or chemotherapy) could not enhance the prognosis of these patients during the last ten to fifteen years. Therefore the investigators chose a new way, as they try to identify markers on a genetic level, who ideally act as a basis to develop new treatment options.

Conditions

  • Soft Tissue and Bone Tumors
  • Sarcoma
  • Sarcoma of Bone
  • Soft Tissue Sarcoma

Interventions

OTHER

Identification and characterization of molecular markers in musculoskeletal tumors

Sponsors & Collaborators

  • Balgrist University Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2018-07-31
Completion
2018-07-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02199938 on ClinicalTrials.gov